|
SR9243
- 英文名称：SR9243
- 品牌：WYTSCI
- 产地：进口
- 型号：1MG
- 货号：WT-AY-B11296
- cas：1613028-81-1
- 价格： ￥1/mg
- 发布日期： 2025-04-10
- 更新日期： 2025-05-23
产品详请
| 产地 | 进口 |
| 品牌 | WYTSCI |
| 货号 | WT-AY-B11296 |
| 用途 | 科研检测 |
| 英文名称 | SR9243 |
| 包装规格 | 1MG |
| CAS编号 | 1613028-81-1 |
| 别名 | SR9243 |
| 纯度 | 98+% |
| 分子式 | |
| 是否进口 | 是 |
纯度:>98% by HPLC;NMR (Conforms)
分子式:C31H32BrNO4S2
分子量:626.62
溶剂:DMSO (>25 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):LXR inverse agonist
Function / Pharmacology:SR9243 is an LXR inverse agonist that significantly inhibits the Warburg effect and lipogenesis by reducing glycolytic and lipogenic gene expression.1 Induces apoptosis in a variety of cancer cell types including SW620 (IC50 = 40 nM), HT-29 (IC50 = 104 nM), DU-145 (IC50 = 15 nM), PC-3 (IC50 = 61 nM), NCI-H23 (IC50 = 72 nM), HOP-62 (IC50 = 26 nM) and MIAPACA-2 (IC50 = 18 nM). SR9243 is able to promote apoptotic cancer cell death without adversely affecting non-malignant cells.
分子式:C31H32BrNO4S2
分子量:626.62
溶剂:DMSO (>25 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):LXR inverse agonist
Function / Pharmacology:SR9243 is an LXR inverse agonist that significantly inhibits the Warburg effect and lipogenesis by reducing glycolytic and lipogenic gene expression.1 Induces apoptosis in a variety of cancer cell types including SW620 (IC50 = 40 nM), HT-29 (IC50 = 104 nM), DU-145 (IC50 = 15 nM), PC-3 (IC50 = 61 nM), NCI-H23 (IC50 = 72 nM), HOP-62 (IC50 = 26 nM) and MIAPACA-2 (IC50 = 18 nM). SR9243 is able to promote apoptotic cancer cell death without adversely affecting non-malignant cells.
